Personal information

Countries

United States

Activities

Collapse all

Education and qualifications (3)

University of North Carolina Wilmington: Wilmingtom, NC, US

Bachelor of Science (Chemistry)
Education
Source: Self-asserted source
Catherine Mills

University of North Carolina Wilmington: Wilmington, NC, US

Master of Science (Chemistry)
Education
Source: Self-asserted source
Catherine Mills

Medical University of South Carolina: Charleston, SC, US

2018-08 to present | PhD (Drug Discovery)
Education
Source: Self-asserted source
Catherine Mills

Professional activities (2)

American Chemical Society: DC, DC, US

Student
Membership
Source: Self-asserted source
Catherine Mills

American Association for the Advancement of Science: DC, DC, US

Student
Membership
Source: Self-asserted source
Catherine Mills

Works (7)

Stimulation of natural killer cells with small molecule inhibitors of CD38 for the treatment of neuroblastoma

Chemical Science
2023 | Journal article
DOI: 10.1039/D2SC05749B
Contributors: Catherine M. Mills; Thomas Z. Benton; Ivett Piña; Megan J. Francis; Leticia Reyes; Nathan G. Dolloff; Yuri K. Peterson; Patrick M. Woster
Source: check_circle
Crossref

Synthesis and evaluation of small molecule inhibitors of LSD1 for use against MYCN-expressing neuroblastoma

European Journal of Medicinal Chemistry
2022-12 | Journal article
DOI: 10.1016/j.ejmech.2022.114818
Contributors: Catherine M. Mills; Jonathan Turner; Ivett C. Piña; Kathleen A. Garrabrant; Dirk Geerts; André S. Bachmann; Yuri K. Peterson; Patrick M. Woster
Source: check_circle
Crossref

New Transmission‐Selective Antimalarial Agents through Hit‐to‐Lead Optimization of 2‐([1,1′‐Biphenyl]‐4‐carboxamido)benzoic Acid Derivatives

ChemBioChem
2022-11-04 | Journal article
DOI: 10.1002/cbic.202200427
Contributors: Janette Reader; Daniel F. L. Opperman; Mariëtte E. van der Watt; Anjo Theron; Meta Leshabane; Shanté da Rocha; Jonathan Turner; Kathleen Garrabrant; Ivett Piña; Catherine Mills et al.
Source: check_circle
Crossref

Application of Pharmacokinetic Prediction Platforms in the Design of Optimized Anti-Cancer Drugs

Molecules
2022-06 | Journal article | Author
DOI: 10.3390/molecules27123678
Contributors: Tyler Beck; Kendra Springs; Jordan E. Morningstar; Catherine Mills; Andrew Stoddard; Lilong Guo; Kelsey S Moore; Cortney Gensemer; Rachel Biggs; Taylor Petrucci et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute
grade
Preferred source (of 2)‎

Small molecules targeting the NADH-binding pocket of VDAC modulate mitochondrial metabolism in hepatocarcinoma cells

Biomedicine & Pharmacotherapy
2022-06 | Journal article
DOI: 10.1016/j.biopha.2022.112928
Part of ISSN: 0753-3322
Contributors: Catherine Mills
Source: Self-asserted source
Catherine Mills

Selective targeting of CD38 hydrolase and cyclase activity as an approach to immunostimulation

RSC Advances
2021-10-11 | Journal article
Source: Self-asserted source
Catherine Mills

Thrombin contributes to cancer immune evasion via proteolysis of platelet-bound GARP to activate LTGF-β

Science Translational Medicine
2020-01-08 | Journal article
DOI: 10.1126/scitranslmed.aay4860
Contributors: Alessandra Metelli; Bill X. Wu; Brian Riesenberg; Silvia Guglietta; John D. Huck; Catherine Mills; Anqi Li; Saleh Rachidi; Carsten Krieg; Mark P. Rubinstein et al.
Source: check_circle
Crossref
How many people are using ORCID?